Literature DB >> 19616182

Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006.

Nicholas G Castle1, Joseph T Hanlon, Steven M Handler.   

Abstract

OBJECTIVE: The aim of this work was to examine the association between organizational characteristics, market characteristics, and changes in antipsychotic medication use in US nursing homes over time.
METHODS: This was a longitudinal study comparing antipsychotic use in US nursing homes from 1996 through 2006 using Medicare and Medicaid data (the Online Survey Certification And Reporting system) and US Department of Health and Human Resources Health Resources and Services Administration data (the Area Resource File). The 3 outcomes of interest were increasing, decreasing, or stable use of antipsychotic medications. The primary independent variables were organizational characteristics (eg, for-profit status, chain membership) and market characteristics (eg, Medicaid reimbursement, levels of competition).
RESULTS: Antipsychotic use increased from 16.4% in 1996 to 25.9% in 2006 (P < 0.05). A multinomial generalized estimating equations model, controlling for facility, staffing, and resident factors, suggested that increased antipsychotic use was associated with for-profit facilities (adjusted odds ratio [AOR], 1.58; 95% CI, 1.51-1.65; P < or = 0.001). Decreased antipsychotic use was associated with chain membership (AOR, 0.82; 95% CI, 0.79-0.85; P < or = 0.001), higher levels of competition (AOR, 1.22; 95% CI, 1.16-1.29; P < or = 0.001), and a higher Medicaid reimbursement rate (AOR, 0.88; 95% CI, 0.85-0.92; P < or = 0.001).
CONCLUSIONS: Antipsychotic use increased in US nursing homes from 1996 through 2006 and was associated with certain organizational characteristics and market characteristics. Future interventions to reduce antipsychotic use in nursing homes will have to focus on these factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616182      PMCID: PMC4867195          DOI: 10.1016/j.amjopharm.2009.05.001

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  31 in total

1.  Does an increase in the Medicaid reimbursement rate improve nursing home quality?

Authors:  D C Grabowski
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2001-03       Impact factor: 4.077

2.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Authors:  I R Katz; D V Jeste; J E Mintzer; C Clyde; J Napolitano; M Brecher
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

3.  The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes.

Authors:  B W Rovner; B A Edelman; M P Cox; Y Shmuely
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

4.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

5.  Atypical antipsychotic medications and risk of falls in residents of aged care facilities.

Authors:  Le T T Hien; Robert G Cumming; Ian D Cameron; Jian S Chen; Stephen R Lord; Lyn M March; Jennifer Schwarz; David G Le Couteur; Philip N Sambrook
Journal:  J Am Geriatr Soc       Date:  2005-08       Impact factor: 5.562

Review 6.  Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

Authors:  Philip E Lee; Sudeep S Gill; Morris Freedman; Susan E Bronskill; Michael P Hillmer; Paula A Rochon
Journal:  BMJ       Date:  2004-06-11

7.  Analysis of repeated categorical data using generalized estimating equations.

Authors:  S R Lipsitz; K Kim; L Zhao
Journal:  Stat Med       Date:  1994-06-15       Impact factor: 2.373

8.  Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.

Authors:  Jane Fossey; Clive Ballard; Edmund Juszczak; Ian James; Nicola Alder; Robin Jacoby; Robert Howard
Journal:  BMJ       Date:  2006-03-16

9.  Variation in nursing home antipsychotic prescribing rates.

Authors:  Paula A Rochon; Therese A Stukel; Susan E Bronskill; Tara Gomes; Kathy Sykora; Walter P Wodchis; Michael Hillmer; Alexander Kopp; Jerry H Gurwitz; Geoffrey M Anderson
Journal:  Arch Intern Med       Date:  2007-04-09

10.  Exposure to antipsychotics and risk of stroke: self controlled case series study.

Authors:  Ian J Douglas; Liam Smeeth
Journal:  BMJ       Date:  2008-08-28
View more
  12 in total

Review 1.  Challenge of changing nursing home prescribing culture.

Authors:  Jennifer Tjia; Jerry H Gurwitz; Becky A Briesacher
Journal:  Am J Geriatr Pharmacother       Date:  2012-01-20

2.  Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes.

Authors:  Jennifer Tjia; Jacob N Hunnicutt; Laurie Herndon; Carolyn R Blanks; Kate L Lapane; Susan Wehry
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

3.  Epidemiology of drug-disease interactions in older veteran nursing home residents.

Authors:  Sherrie L Aspinall; Xinhua Zhao; Todd P Semla; Francesca E Cunningham; Allison M Paquin; Mary Jo Pugh; Kenneth E Schmader; Roslyn A Stone; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2014-12-23       Impact factor: 5.562

4.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02

5.  The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homes.

Authors:  Sherrie L Aspinall; Xinhua Zhao; Steven M Handler; Roslyn A Stone; Janine C Kosmoski; Elizabeth A Libby; Susan Dove Francis; David A Goodman; Rebecca D Roman; Heather L Bieber; Jennifer M Voisine; Sean M Jeffery; Charley A Hepfinger; Diane G Hagen; Micki M Martin; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2010-07-19       Impact factor: 5.562

6.  Use of antipsychotics among older residents in VA nursing homes.

Authors:  Walid F Gellad; Sherrie L Aspinall; Steven M Handler; Roslyn A Stone; Nicholas Castle; Todd P Semla; Chester B Good; Michael J Fine; Maurice Dysken; Joseph T Hanlon
Journal:  Med Care       Date:  2012-11       Impact factor: 2.983

7.  Inappropriate Antipsychotic Use: The Impact of Nursing Home Socioeconomic and Racial Composition.

Authors:  Shekinah Fashaw; Latarsha Chisholm; Vincent Mor; David J Meyers; Xinliang Liu; Denise Gammonley; Kali Thomas
Journal:  J Am Geriatr Soc       Date:  2020-01-22       Impact factor: 5.562

8.  Antipsychotic use in nursing homes varies by psychiatric consultant.

Authors:  Jennifer Tjia; Terry Field; Celeste Lemay; Kathleen Mazor; Michelle Pandolfi; Ann Spenard; Shih-Yieh Ho; Abir Kanaan; Jennifer Donovan; Jerry H Gurwitz; Becky Briesacher
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

9.  Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment.

Authors:  Barbara Resnick; Ann Kolanowski; Kimberly Van Haitsma; Elizabeth Galik; Marie Boltz; Jeanette Ellis; Liza Behrens; Karen Eshraghi; Shijun Zhu
Journal:  Clin Nurs Res       Date:  2019-04-03       Impact factor: 2.075

Review 10.  Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.

Authors:  Hannah Cioltan; Samah Alshehri; Carol Howe; Jeannie Lee; Mindy Fain; Howard Eng; Kenneth Schachter; Jane Mohler
Journal:  BMC Geriatr       Date:  2017-01-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.